Pharmacognosy intro
Motherwort bridges the cardiovascular and nervous systems through a unique alkaloid and terpenoid profile. Its signature compound leonurine, a guanidine alkaloid unique to the Leonurus genus, is present at 0.02-0.1%, accompanied by stachydrine (proline betaine, 0.1-1%), labdane diterpenes including leocardin and leosibirin, additional alkaloids leonuridine and leonurinine, ursolic acid, flavonoid glycosides (rutin, quercetin, hyperoside), and iridoid glycosides including leonuride. Leonurine's cardioprotective mechanisms include vascular smooth muscle relaxation via NO-mediated and calcium channel blocking mechanisms, negative chronotropic activity (slowing heart rate with anti-palpitation effects), and protection against ischemia-reperfusion injury through antioxidant and anti-apoptotic pathways. Critically, the extract demonstrates direct GABA-A receptor binding with IC50 of 21 microg/mL for crude extract and 15 microg/mL for leonurine, explaining the anxiolytic and sedative properties that make motherwort the quintessential herb for anxiety with cardiovascular expression. Uterotonic activity through increased uterine contraction strength and frequency underpins traditional postpartum and menstrual use. Evidence of anti-thyroid activity may reduce TSH and thyroid hormone levels in hyperthyroid states. Clinical evidence includes an open-label study (n=50) of Leonurus oil extract 1200mg/day for 28 days in stage 1-2 arterial hypertension with anxiety, showing 80% of patients with significant or moderate improvement in anxiety and depression symptoms. The German Commission E approved motherwort for nervous cardiac conditions and as adjuvant in thyroid hyperfunction.